Skip to main content

Table 2 Costs of care in the baseline and programme periods

From: Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme

  Pre-Programme1   Programme2   Change3,4    
  Mean (SD) Mean (SD) Mean 95% CI4 N p
Cost (£, 2011)         
Programme    32.00 - 32.00 - - -
Emollient [A] 9.29 (9.30) 19.57 (12.03) 10.28 (7.93 to 12.64) 132 0.001
Emollient [B] 9.72 (9.69) 22.64 (12.21) 12.91 (10.72 to 15.10) 115 0.001
GP visits 68.53 (76.70) 30.40 (31.67) -38.13 (-52.58 to -23.68) 135 0.001
Overall cost [A] 78.29 (79.34) 82.66 (34.16) 4.37 (-10.55 to 19.30) 132 0.62
Overall cost [B] 80.32 (82.48) 84.37 (31.29) 4.06 (-12.00 to 20.11) 115 0.56
  1. 1 Estimated for the 12 weeks preceding intervention, using 2 week baseline data and 12 week recall (GP visits).
  2. 2 Twelve weeks while receiving the patient support programme.
  3. 3 Difference in costs in the two periods (negative denotes a reduction).
  4. 4 Estimated by bootstrapping with 1,000 replications.
  5. A Emollient use costed using the daily diary method.
  6. B Emollient use costed using the estimated time taken to use a 500 g pot of emollient.